IL31 and asthma: The results demonstrated that higher levels of IL-31 in peripheral blood and elevated IL-31 mRNA in lungs persistently existed during 2 months of airway inflammation, although with a slight decrease at later time-points as compared with those at day 28, indicating that IL-31 modulated the development of airway inflammation in asthma.